StockNews.com assumed coverage on shares of Precigen (NASDAQ:PGEN – Free Report) in a research report sent to investors on Tuesday. The firm issued a sell rating on the biotechnology company’s stock. Several other brokerages have also issued reports on PGEN. HC Wainwright restated a buy rating and issued a $6.00 target price on shares of […]

Related Keywords

Hong Kong , Helen Sabzevari , Steven Frank , Precigen Company Profile , Wells Fargo Company , Precigen Inc , Nasdaq , Securities Exchange Commission , Intercept Hong Kong Ltd , Jpmorgan Chase Co , Free Report , Stock Down , Director Steven Frank , Exchange Commission , Street Corp , Get Free Report , Precigen Daily , Precigen , Nasdaq Pgen , Opgen , Medical , Initiated Coverage , Stocknews Com ,